Evidence map›Paper›PMID 41341211›Full record

ReviewJournal of inflammation research2025

Targeting PANoptosis in Bacterial-Induced Inflammatory Diseases: Mechanisms and Therapeutic Interventions.

Tianyin Wang, Yini Lu, Xiong Zhang, Feng Yu

Abstract readReview
In one paragraph

Review in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Advances in the molecular pathogenesis ofFrontiers in cellular and infection microbiology · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tianyin WangDepartment of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, People's Republic of China.
Yini LuDepartment of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, People's Republic of China.
Xiong ZhangDepartment of Criminal Science and Technology, Jiangsu Police Institute, Nanjing, Jiangsu, 210031, People's Republic of China.ORCID 0000-0002-1084-523X
Feng YuDepartment of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PANoptosis is a novel form of cell death that integrates necroptosis, apoptosis, and pyroptosis, along with their crosstalk, mediated and regulated by the PANoptosome. This review focuses on bacterial PANoptosis, systematically summarizing through distinct pathways and virulence factors, and analyzing its role in inflammatory diseases. Furthermore, we discuss potential therapeutic interventions related to PANoptosis in bacterial inflammation, establishing a framework for novel anti-inflammatory drug development. Understanding the mechanisms of bacteria-induced PANoptosis may provide new strategies for targeted intervention in inflammatory responses to infection.

Indexed as

gram-negative bacteriagram-positive bacteriaPANoptosisPANoptosomepotential therapeutic targets

Identifiers

PMID41341211
PMCPMC12669053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.